Inventor · disambiguated record
Bernard Moss
Also filed as: MOSS BERNARD
44 granted patents·6 pending applications·874 citations·filing 1984–2019
98Inventor score
Files withUS HEALTH21MOSS BERNARD6US COMMERCE5ROBINSON HARRIET L2THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
50 records- 0193US6998252B1Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequencesUS HEALTH·Filed 1995·Granted Feb 14, 2006·121 cites·14 claims
- 0292US9133480B2Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sitesMOSS BERNARD·Filed 2010·Granted Sep 15, 2015·23 cites·20 claims
- 0390US9133478B2Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genesMOSS BERNARD·Filed 2007·Granted Sep 15, 2015·17 cites·23 claims
- 0490US7208313B2Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vectorUS HEALTH·Filed 2001·Granted Apr 24, 2007·53 cites·23 claims
- 0590US7045313B1Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNAUS HEALTH·Filed 1992·Granted May 16, 2006·86 cites·17 claims
- 0689US8506947B2Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cellMCCART J ANDREA·Filed 2007·Granted Aug 13, 2013·27 cites·20 claims
- 0788US9879231B2Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sitesUS HEALTH·Filed 2015·Granted Jan 30, 2018·7 cites·20 claims
- 0887US8916172B2MVA expressing modified HIV envelope, gag, and pol genesMOSS BERNARD·Filed 2011·Granted Dec 23, 2014·9 cites·4 claims
- 0987US7867982B2MVA expressing modified HIV envelope, gag, and pol genesUNIV EMORY·Filed 2008·Granted Jan 11, 2011·3 cites·2 claims
- 1085US9453239B2Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genesMOSS BERNARD·Filed 2005·Granted Sep 27, 2016·7 cites·16 claims
- 1185US7303754B2MVA expressing modified HIV envelope, gag, and pol genesUS HEALTH·Filed 2005·Granted Dec 4, 2007·12 cites·14 claims
- 1284US7914788B2Monoclonal antibodies against orthopoxvirusesUS HEALTH·Filed 2008·Granted Mar 29, 2011·3 cites·15 claims
- 1382US5676950AEnterically administered recombinant poxvirus vaccinesUNIV FLORIDA·Filed 1995·Granted Oct 14, 1997·77 cites·12 claims
- 1478US5206353ACD-4/cytotoxic gene fusionsUS COMMERCE·Filed 1988·Granted Apr 27, 1993·26 cites·9 claims
- 1578US5135855ARapid, versatile and simple system for expressing genes in eukaryotic cellsUS HEALTH·Filed 1989·Granted Aug 4, 1992·49 cites·12 claims
- 1677US5157110ASynthetic, anti-complement proteinUS HEALTH·Filed 1988·Granted Oct 20, 1992·37 cites·5 claims
- 1776US9254319B2Compositions and methods for generating an immune responseUNIV EMORY·Filed 2013·Granted Feb 9, 2016·2 cites·22 claims
- 1876US5587455ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1994·Granted Dec 24, 1996·28 cites·8 claims
- 1972US10421978B2Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virusTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Sep 24, 2019·1 cites·16 claims
- 2071US6171596B1Oligomeric HIV-1 envelope glycoproteinsUS HEALTH·Filed 1998·Granted Jan 9, 2001·35 cites·5 claims
- 2169US7494813B2VAC-BAC shuttle vector systemUS HEALTH·Filed 2004·Granted Feb 24, 2009·1 cites·41 claims
- 2267US7015024B1Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequencesUS HEALTH·Filed 1995·Granted Mar 21, 2006·22 cites·18 claims
- 2367US5336758APeptides stimulating cytotoxic T cells immune to HIV RTUS HEALTH·Filed 1990·Granted Aug 9, 1994·23 cites·3 claims
- 2467US5151509AGene encoding serine protease inhibitorUSA·Filed 1988·Granted Sep 29, 1992·19 cites·2 claims
- 2567US2015238593A1Mva expressing modified hiv envelope, gag and pol genesMOSS BERNARD·Filed 2014·Application pending·0 cites
- 2665US5126251AStable mammalian cell line expressing a bacteriophage RNA polymeraseUS HEALTH·Filed 1990·Granted Jun 30, 1992·27 cites·13 claims
- 2764US8999336B2Monoclonal antibodies against OrthopoxvirusesUS HEALTH·Filed 2013·Granted Apr 7, 2015·0 cites·13 claims
- 2862US4738846AVaccine for vesicular stomatitis virusSALK INST FOR BIOLOGICAL STUDI·Filed 1984·Granted Apr 19, 1988·21 cites·6 claims
- 2961US2004146528A1MVA expressing modified HIV envelope, gag, and pol genesFiled 2003·Application pending·0 cites
- 3060US9708392B2Monoclonal antibodies against orthopoxvirusesUS HEALTH·Filed 2015·Granted Jul 18, 2017·0 cites·12 claims
- 3159US5849304ARecombinant vaccinia virus expressing human retrovirus geneUS COMMERCE·Filed 1995·Granted Dec 15, 1998·13 cites·20 claims
- 3259US2020071724A1Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia VirusTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2019·Application pending·0 cites
- 3358US8404818B2Monoclonal antibodies against orthopoxvirusesCHEN ZHAOCHUN·Filed 2011·Granted Mar 26, 2013·0 cites·19 claims
- 3458US7045136B1Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequencesUS HEALTH·Filed 1995·Granted May 16, 2006·14 cites·5 claims
- 3556US6780417B2Transmission blocking immunogen from malariaUS HEALTH·Filed 1995·Granted Aug 24, 2004·19 cites·4 claims
- 3655US6039957AOligomeric HIV-1 envelope glycoproteinsUS HEALTH·Filed 1997·Granted Mar 21, 2000·8 cites·5 claims
- 3755US2007048861A1Compositions and methods for generating an immune responseROBINSON HARRIET L·Filed 2006·Application pending·0 cites
- 3854US5550035AProkaryotic expression in eukaryotic cellsUNIV NEW YORK STATE RES FOUND·Filed 1994·Granted Aug 27, 1996·16 cites·43 claims
- 3953US5506138ARecombinant vaccinia virus encoding cytochromes P-450US ARMY·Filed 1993·Granted Apr 9, 1996·11 cites·9 claims
- 4053US5428143ACytotoxic agent against specific virus infectionUS COMMERCE·Filed 1993·Granted Jun 27, 1995·9 cites·1 claims
- 4151US5164313ARecombinant vaccinia virus encoding cytochromes P-450US HEALTH·Filed 1991·Granted Nov 17, 1992·10 cites·8 claims
- 4251US2011159036A1MVA expressing modified HIV envelope, GAG, and POL genesMOSS BERNARD·Filed 2007·Application pending·0 cites
- 4349US8124105B2Compositions, methods and kits relating to poxvirus subunit vaccinesCOHEN GARY H·Filed 2009·Granted Feb 28, 2012·0 cites·4 claims
- 4449US7560116B2Compositions, methods and kits relating to poxvirus subunit vaccinesUNIV PENNSYLVANIA·Filed 2004·Granted Jul 14, 2009·0 cites·18 claims
- 4548US5866383AIn vitro ligation of foreign DNA into large eukaryotic virusesUS HEALTH·Filed 1992·Granted Feb 2, 1999·18 cites·19 claims
- 4648US5187268AGene encoding an anti-complement protein from vacciniaUS HEALTH·Filed 1992·Granted Feb 16, 1993·9 cites·2 claims
- 4744US10894966B2Virus-based expression vectors and uses thereofTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2015·Granted Jan 19, 2021·0 cites·33 claims
- 4841US5348741AVector for recombinant poxvirus expressing rabies virus glycoproteinUS ARMY·Filed 1992·Granted Sep 20, 1994·11 cites·20 claims
- 4937US2015231227A1Compositions and methods for generating an immune responseROBINSON HARRIET L·Filed 2010·Application pending·0 cites
- 5027US5770210ARecombinant vaccinia virus expressing human retrovirus geneUS COMMERCE·Filed 1992·Granted Jun 23, 1998·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Bernard Moss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →